ATC code - B03AA07
PolandFerrous sulfate
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC code: B03AA07
Manufacturer: EGIS Pharmaceuticals PLC
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC code: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC code: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC code: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC code: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC code: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC code: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 100 mg ascorbic acid 60 mg ATC code: B03AA07
Manufacturer: Egis Pharmaceuticals PLC
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Ibérica, S.A.
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Iberica, S.A.
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Ibérica, S.A.
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament
-
Form: tablets, prolonged release
ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament
-
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Farmaka A.E.
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Farmaka A.E.
-
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Iberica, S.A.
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Iberica, S.A.
-
Form: tablets, modified release
Active substance Dosage ferrous sulfate 80 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament
-
Form: tablets, prolonged release
Active substance Dosage ferrous sulfate 80 mg folic acid 0.35 mg ATC code: B03AA07
Manufacturer: Pierre Fabre Farmaka A.E.
-
Form: solution, oral
Active substance Dosage iron 20 mg/ml ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament Production
-
Form: solution, oral
Active substance Dosage iron 20 mg/ml ATC code: B03AA07
Manufacturer: Pierre Fabre Medicament Production